HIV/AIDS Quality of Life
Quality of life similar with long-cycle structured intermittent versus continuous HAART
Published in Medical Letter on the CDC and FDA, June 14th, 2006
In a recent report published in the journal AIDS, researchers in the United States conducted a study to "examine the effect of repeated, long-cycle structured intermittent versus continuous HAART on health-related quality of life (HRQL) and symptom distress in patients with chronic HIV infection and plasma HIV RNA of less than 50 copies/mL."
A prospective "survey of adult patients (n=46) enrolled in a randomized clinical trial evaluating intermittent versus continuous HAART on immunological and virologic parameters" was...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA
More Articles from Medical Letter on the CDC and FDA
- Addiction Medicine
Unintentional prescription drug overdose deaths increase in New Mexico - Diabetes Epidemiology
Diabetes incidence is increasing in U.S. adults - Food Safety
Method to quantify tetrabromotetrachloro-fluorescein analog in color additives is developed - Hepatitis B Outbreak
Methamphetamine injectors are at high risk for hepatitis B virus infection - Streptococcal Vaccine
Opsonophagocytic assays to identify Streptococcus pneumoniae antibodies were evaluated - Adenovirus Vaccine
Adenoviral respiratory illness in U.S. military recruits is increasing - More from this issue of Medical Letter on the CDC and FDA
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
